Betaxolol adverse reactions: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Betaxolol}} {{CMG}}; {{AE}} {{SS}} ==Adverse Reactions== The following adverse reactions have been reported in clinical trials with BETOPTIC Ophthalmic Solution. ...")
 
(Redirected page to Betaxolol#Adverse Reactions)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Betaxolol#Adverse Reactions]]
{{Betaxolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Adverse Reactions==
The following adverse reactions have been reported in clinical trials with BETOPTIC Ophthalmic Solution.
 
===Ocular===
 
Discomfort of short duration was experienced by one in four patients, but none discontinued therapy; occasional tearing has been reported. Rare instances of decreased corneal sensitivity, [[erythema]], itching sensation, corneal punctate staining, [[keratitis]], [[anisocoria]], [[edema]], and [[photophobia]] have been reported.
 
Additional medical events reported with other formulations of betaxolol include blurred vision, foreign body sensation, dryness of the eyes, inflammation, discharge, ocular pain, decreased visual acuity, and crusty lashes.
 
===Systemic===
 
Systemic reactions following administration of BETOPTIC Ophthalmic Solution 0.5% or BETOPTIC S Ophthalmic Suspension 0.25% have been rarely reported. These include:
 
===Cardiovascular===
 
[[Bradycardia]], heart block and congestive failure.
 
===Pulmonary===
 
Pulmonary distress characterized by [[dyspnea]], [[bronchospasm]], thickened bronchial secretions, [[asthma]] and [[respiratory failure]].
 
===Central Nervous System===
 
[[Insomnia]], [[dizziness]], [[vertigo]], [[headache]]s, [[depression]], [[lethargy]], and increase in signs and symptoms of [[myasthenia gravis]].
 
===Other===
 
[[Hives]], [[toxic epidermal necrolysis]], hair loss and [[glossitis]].
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BETOPTIC (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [ALCON] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31b9b263-11fd-4495-83dd-ababf0d70e9e | publisher =  | date =  | accessdate = 3 February 2014 }}</ref>
 
 
 
==References==
 
{{Reflist|2}}


[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 16:17, 21 July 2014